TTY Biopharm Co Ltd Cash Flow Quality Index
TTY Biopharm Co Ltd cash flow quality index. TTY Biopharm Co Ltd (4105) has a Cash Flow Quality Index of 1.48x as of March 2026. Operating cash flow of NT$654.16 Million exceeds net income of NT$443.06 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of TTY Biopharm Co Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of TTY Biopharm Co Ltd (2017–2025)
Cash flow quality index of TTY Biopharm Co Ltd from 2017 to 2025. Historical Cash Flow Quality Index for TTY Biopharm Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 4105 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
TTY Biopharm Co Ltd Cash Flow Quality Index by Year (2017–2025)
TTY Biopharm Co Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for TTY Biopharm Co Ltd. For the full cash flow conversion analysis, see TTY Biopharm Co Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | NT$1.76 Billion | NT$1.56 Billion | ▲ +21.4% |
| 2024 | 0.93x | NT$1.35 Billion | NT$1.45 Billion | ▲ +21.7% |
| 2023 | 0.76x | NT$1.09 Billion | NT$1.42 Billion | ▼ -12.9% |
| 2022 | 0.88x | NT$1.24 Billion | NT$1.41 Billion | ▼ -24.1% |
| 2021 | 1.16x | NT$1.26 Billion | NT$1.09 Billion | ▲ +163.7% |
| 2020 | 0.44x | NT$526.35 Million | NT$1.20 Billion | ▼ -67.4% |
| 2019 | 1.34x | NT$1.21 Billion | NT$900.08 Million | ▲ +82.9% |
| 2018 | 0.73x | NT$1.07 Billion | NT$1.46 Billion | ▼ -0.8% |
| 2017 | 0.74x | NT$996.52 Million | NT$1.34 Billion | — |